Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 126

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 126
---
 These competitors
may have more experience than we have in research and development, marketing, manufacturing, preclinical testing, conducting clinical
studies, obtaining FDA and/or foreign regulatory approvals or certifications and marketing approved or certified products. Our competitors
may discover technologies and techniques, or enter into partnerships and collaborations, to develop competing products that are more effective
or less costly than our products or the products we may develop. There can be no assurance that other companies will not succeed in developing
or marketing devices and products that are more effective than our technology or products or that would render our technology or products
obsolete or noncompetitive. Academic institutions, government agencies, and other public and private research organizations may seek patent
protection regarding potentially competitive products or technologies and may establish exclusive collaborative or licensing relationships
with our competitors. Our competitors may be better equipped than we are to respond to competitive pressures. Competition will likely
intensify.

Additionally,
many companies in the healthcare industry, including healthcare provider systems, are consolidating to create new companies with greater
market power, and we expect that to continue. As the healthcare industry consolidates, competition to provide goods and services to industry
participants will become more intense. These industry participants may try to use their market power to negotiate price concessions or
reductions for medical products including those produced by us. If we reduce our prices because of consolidation in the healthcare industry,
our revenue would decrease and our consolidated earnings, financial condition, or cash flows would suffer.

Our operating results may
fluctuate significantly, which makes our future operating results difficult to predict and could cause our operating results to fall below
expectations or any guidance we may provide.

Our quarterly
and annual operating results may fluctuate significantly, making it difficult for us to predict our future operating results. These fluctuations
may occur due to a variety of factors, many of which are outside of our control. These factors could include, among others:

| ● | the timing and cost of, and level of investment in, research, development, regulatory approval or certification 
 and commercialization activities relating to our products, which may change from time to time;                  |

| ● | the ability to obtain, and timing and cost of obtaining regulatory approvals or certifications for planned 
 or future products or indications;                                                                         |

| ● | the timing and success or failure of preclinical studies or clinical studies for our products, future 
 products we develop or competing products, and the impact of competition in our industry;             |

| ● | the level of demand for